Julia Lainster

In this exclusive conversation, we delve into the complexities of the cell culture market with Ivan Kairatov, a seasoned biopharma expert. His insights into the tech-driven evolution of this sector highlight the potential for innovation in drug discovery and development. How do you perceive the

The rising number of fentanyl-related overdose deaths and the dramatic increase in accidental exposures among children have highlighted the urgent need for enhanced biohazard training for first responders and property managers. Fentanyl's exceptional potency and widespread presence present

At-home diagnostic testing is entering a new era thanks to the collaboration between Ginkgo Automation and Aura Genetics. Together, they aim to accelerate innovation in the healthcare and wellness markets by leveraging advanced laboratory automation and technologies to streamline and scale

The rapid advancements in artificial intelligence (AI) have begun to significantly impact various domains, including virology. A recent study has shed light on the remarkable capabilities of AI models like ChatGPT and Claude, which have proven to surpass PhD-level virologists in solving complex lab

In the quest to understand and treat cancer, researchers have faced significant obstacles with traditional models such as two-dimensional cell cultures and in vivo xenografts. These methods, while useful in their own right, often fall short in accurately replicating the complex architecture and

The realm of advanced materials has witnessed a groundbreaking development with the introduction of molecular chainmail by researchers at Westlake University. Led by Professor Zhichang Liu, this innovative work in polymer science has resulted in a two-dimensional (2D) mechanically interlocked

In the dynamic world of modern medicine, expectations run high for treatments that are not only effective but also minimize risks. Yet, conventional cancer therapies often walk a fine line between disease eradication and severe side effects. What if there was a way to tailor treatments to each

Allogene Therapeutics, a clinical-stage biotechnology company based in South San Francisco, has achieved a groundbreaking milestone. Their investigational product, ALLO-329, has received three Fast Track Designations (FTDs) from the FDA, marking a significant advancement in the treatment of

In the ongoing battle against water contamination, few pollutants have proven as tenacious as per- and polyfluoroalkyl substances (PFAS), frequently dubbed “forever chemicals.” These resistant compounds are omnipresent in various products, including food packaging and nonstick coatings, posing env

In a groundbreaking initiative, Burjeel Holdings is joining forces with Caring Cross to establish advanced biomanufacturing facilities dedicated to chimeric antigen receptor (CAR)-T cell therapies in the United Arab Emirates (UAE). This collaboration aims to revolutionize the production and